Covered recipient · General Payments record
NIZAMUDDIN J MARUF
Allopathic & Osteopathic Physicians Urology
General Payments · PY2019–2025
$7,066.97
- Reported across 213 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $498.28 | 8 |
| Education | $35.06 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $148.05 | 1 |
| IMMUNITYBIO, INC. | $135.17 | 1 |
| Merck Sharp & Dohme Corporation | $107.86 | 1 |
| Acerta Pharma LLC | $58.38 | 2 |
| CIVCO Medical Instruments | $24.16 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $22.54 | 1 |
| ABBVIE INC. | $22.40 | 1 |
| Myriad Genetic Laboratories, Inc. | $14.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.40 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203029568 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.32 | 04/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206340369 | CMS |
| AstraZeneca Pharmaceuticals LP | $35.06 | 11/19/2025 | Education | Undisputed | 06/30/2026 | 1206335547 | CMS |
| CIVCO Medical Instruments | $24.16 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248978752 | CMS |
| IMMUNITYBIO, INC. | $135.17 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233175793 | CMS |
| Janssen Biotech, Inc. | $148.05 | 04/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174719511 | CMS |
| Merck Sharp & Dohme LLC | $107.86 | 04/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238019738 | CMS |
| Myriad Genetic Laboratories, Inc. | $14.78 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245407810 | CMS |
| PROGENICS PHARMACEUTICALS, INC. | $22.54 | 02/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245237614 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.